Rapidly dividing cancer cells have an increased need for DNA synthesis, making them more dependent on TS activity. Elevated levels of TS have been observed in various types of cancers, including colorectal, gastric, and breast cancer. Overexpression of TS is often associated with poor prognosis and resistance to certain chemotherapeutic agents, such as fluoropyrimidines, which target this enzyme.
